NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other CancersWen Zhou, Fenghuang Zhan, Ye Yang et al.|Cancer Cell|2013Cited by 302
The mitotic serine threonine kinase, <i>Aurora-2</i>, is a potential target for drug development in human pancreatic cancerSangeeta Rojanala, David J. Bearss|Molecular Cancer Therapeutics|2004Cited by 78
Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinomaDevalingam Mahalingam, Steffan T. Nawrocki, Claudia M. Espitia et al.|British Journal of Cancer|2011Cited by 28
A small molecule inhibitor of Pim-1 kinase with activity in both hematological and solid tumor malignanciesJeremy Lamb, David J. Bearss, Eric Gourley et al.|Molecular Cancer Therapeutics|2007Cited by 2
Targeting Pim Kinases in Hematological Malignancies.Eric Gourley, David J. Bearss, Xiaohui Liu et al.|Blood|2007Cited by 1